Home › Agammaglobulinemia
Agammaglobulinemia clinical trials recruiting in the U.S.
6 studies for Agammaglobulinemia are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)
RecruitingObservational study
Ages 2 to 120 · All sexes · Updated Oct 2, 2026 · NCT00001244A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT05645107Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07220915Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07648264Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06976476IVIG vs SCIG in CIDP
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Dec 11, 2025 · NCT05584631From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.